Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020138428 - THERAPEUTIC AGENT FOR INHERITED BRADYARRHYTHMIA

Publication Number WO/2020/138428
Publication Date 02.07.2020
International Application No. PCT/JP2019/051456
International Filing Date 27.12.2019
IPC
A61P 9/06 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
06Antiarrhythmics
A61K 31/353 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
A61K 31/4741 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
47Quinolines; Isoquinolines
4738ortho- or peri-condensed with heterocyclic ring systems
4741condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
CPC
A61K 31/353
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
A61K 31/4741
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
47Quinolines; Isoquinolines
4738ortho- or peri-condensed with heterocyclic ring systems
4741condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
A61P 9/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
06Antiarrhythmics
Applicants
  • 国立大学法人大阪大学 OSAKA UNIVERSITY [JP]/[JP]
  • 日産化学株式会社 NISSAN CHEMICAL CORPORATION [JP]/[JP]
Inventors
  • 朝野 仁裕 ASANO, Yoshihiro
  • ▲高▼島 成二 TAKASHIMA, Seiji
  • 山田 憲明 YAMADA, Noriaki
  • 山下 徹 YAMASHITA, Toru
Agents
  • 特許業務法人はなぶさ特許商標事務所 HANABUSA PATENT & TRADEMARK OFFICE
Priority Data
2018-24791928.12.2018JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) THERAPEUTIC AGENT FOR INHERITED BRADYARRHYTHMIA
(FR) AGENT THÉRAPEUTIQUE POUR BRADYARHYTMIE HÉRÉDITAIRE
(JA) 遺伝性徐脈性不整脈治療薬
Abstract
(EN)
[Problem] To provide a therapeutic agent for inherited bradyarrhythmia. [Solution] A therapeutic agent for bradyarrhythmia, which contains a compound (I) or (II) or a pharmacologically acceptable salt thereof as an active ingredient. (In the formula, Ph represents a phenyl group.)
(FR)
Le problème à résoudre est de trouver un agent thérapeutique pour la bradyarythmie héréditaire. La solution apportée est un agent thérapeutique pour la bradyarythmie qui contient un composé (I) ou (II) ou un sel pharmaceutiquement acceptable de celui-ci en tant que principe actif. (Dans La formule, Ph représente un groupe phényle.)
(JA)
【課題】遺伝性徐脈性不整脈治療薬を提供する。 【解決手段】下記の化合物(I)若しくは化合物(II)又はそれらの薬理学的に許容される塩を有効成分として含む徐脈性不整脈の治療剤。 (式中、Phはフェニル基を表す。)
Also published as
JP2020562502
Latest bibliographic data on file with the International Bureau